1. TNFRSF1B Gene Variants in Clinicopathological Aspects and Prognosis of Patients with Cutaneous Melanoma
   Bruna Fernandes Carvalho et al, 2024, International Journal of Molecular Sciences CrossRef
2. TNFR2-expressing CD4+Foxp3+ regulatory T cells in cancer immunology and immunotherapy
   Jiang He et al, 2019, Cancer Immunotherapy CrossRef
3. Effects of miR-107 on the Chemo-drug sensitivity of breast cancer cells
   Yong Luo et al, 2019, Open Medicine CrossRef
4. DNA repair pathways in breast cancer: from mechanisms to clinical applications
   Muhammad Tufail, 2023, Breast Cancer Research and Treatment CrossRef
5. TNFR2: A Novel Target for Cancer Immunotherapy
   Éva S. Vanamee et al, 2017, Trends in Molecular Medicine CrossRef
6. TNF Receptor 2 Makes Tumor Necrosis Factor a Friend of Tumors
   Yuqiao Sheng et al, 2018, Frontiers in Immunology CrossRef
7. The Roles of TNFR2 Signaling in Cancer Cells and the Tumor Microenvironment and the Potency of TNFR2 Targeted Therapy
   Hiroyuki Takahashi et al, 2022, Cells CrossRef
8. Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer
   Muchun Li et al, 2022, Frontiers in Oncology CrossRef
9. ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite Signalling
   Samantha A Hutchinson et al, 2019, Nutrients CrossRef
10. Deletion of the non-adjacent genes UL148 and UL148D impairs human cytomegalovirus-mediated TNF receptor 2 surface upregulation
    Vu Thuy Khanh Le-Trilling et al, 2023, Frontiers in Immunology CrossRef
11. TNFR2: Role in Cancer Immunology and Immunotherapy
    Yang Yang et al, 2021, ImmunoTargets and Therapy CrossRef
12. Mechanism of the enhancing effects of miR‑93 on resistance of breast cancer MCF‑7 cells to adriamycin
    Qian Wang et al, 2018, Oncology Letters CrossRef
13. Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy
    Juliane Medler et al, 2022, Cancers CrossRef
14. Downregulation of TNFR2 decreases survival gene expression, promotes apoptosis and affects the cell cycle of gastric cancer cells
    Ana Flávia Teixeira Rossi et al, 2022, World Journal of Gastroenterology CrossRef
15. Tumor Necrosis Factor α: Taking a Personalized Road in Cancer Therapy
    Adit Ben-Baruch, 2022, Frontiers in Immunology CrossRef
16. Unraveling the Cellular Mechanism of Assembling Cholesterols for Selective Cancer Cell Death
    Huaimin Wang et al, 2019, Molecular Cancer Research CrossRef
17. Silencing of the cytokine receptor TNFRSF13B: A new therapeutic target for triple-negative breast cancer
    Mahmoud T. Abo-Elfadl et al, 2020, Cytokine CrossRef
18. Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy
    Tamir Baram et al, 2021, Frontiers in Oncology CrossRef
19. Clinical significance of tumor necrosis factor receptor 2 in middle and lower thoracic esophageal squamous cell carcinoma
    Dong Yang et al, 2018, Oncology Letters CrossRef
20. Expression of tumor necrosis factor receptor 2 in human non‐small cell lung cancer and its role as a potential prognostic biomarker
    Yan Wen Zhang et al, 2019, Thoracic Cancer CrossRef
21. A Perspective Review on the Role of Nanomedicine in the Modulation of TNF-TNFR2 Axis in Breast Cancer Immunotherapy
    Mohammad A. I. Al-Hatamleh et al, 2019, Journal of Oncology CrossRef
22. The distinct role of CD73 in the progression of pancreatic cancer
    Liangjing Zhou et al, 2019, Journal of Molecular Medicine CrossRef
23. The Immunosuppressive Effect of TNFR2 Expression in the Colorectal Cancer Microenvironment
    Nurul Hakimah Mohd Salim et al, 2023, Biomedicines CrossRef